Assorted News from the Last Week: CAC2 Supporting Organization Day One Biopharmaceuticals announced that Ibsen was awarded conditional marketing authorization for tovorafenib for children with
Assorted News from the Last Week: New clinical trials open: Beat Childhood Cancer Research Consortium will evaluate whether the drug eflornithine (DFMO) can help prevent
Assorted News from the Last Week: The ARPA-H Pediatric Care eXpansion (PCX) initiative is a $50 million program launched in January 2026 to create a
Assorted News from the Last Week: CAC2 Individual Member Laura DeKraker Lang-Ree provides a crucial look at self-advocacy for children and families with cancer in
Assorted News from the Last Week: Over the past year, CAC2 supporting organization member LifeArc has hosted a series of workshops to discuss the latest
Assorted News from the Last Week: State advocacy news from Sahil Mehta, son of CAC2 Members Misha Mehta and Sandeep Kolte (Neev Kolte & Brave
Assorted News from the Last Week: Featured CAC2 blog post this week: Summer Camps for Kids with Cancer: A Family Guide. CAC2 Members (Mattie Miracle
Assorted News from the Last Week: Catch the latest CAC2 Blog Post: Celebrating Progress: Big legislative wins for our community. Acquisition news for CAC2 Supporting
Assorted News from the Last Week: Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations. Making symptoms visible: The
Assorted News from the Last Week: Jordan receives first shipment of life-saving childhood cancer medicines through the global platform. AI-powered liquid biopsy can classify pediatric
